Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

August 1, 2025

Study Completion Date

July 1, 2026

Conditions
Melasma
Interventions
PROCEDURE

1565 nm non-ablative fractional laser combined with normal saline

After 1565 nm non-ablative fractional laser treatment, patients with melasma were smeared with normal saline and to compared with those smeared with exosomes after laser treatment.

PROCEDURE

microneedles combined with hUCMSC-Exos

the hUCMSC-Exos were applied while rolling a microneedle roller and to compared with those used 1565 nm non-ablative fractional laser or PBASM combined with hUCMSC-Exos.

PROCEDURE

1565 nm non-ablative fractional laser combined with hUCMSC-Exos

After 1565 nm non-ablative fractional laser treatment, patients with melasma were smeared with hUCMSC-Exos and to compared with those smeared with normal saline after laser treatment.What's more,compared with those used microneedles or PBASM combined with hUCMSC-Exos.

PROCEDURE

PBASM combined with hUCMSC-Exos

a plasma named Peninsula Blue Aurora Shumin Master (PBASM) rolling each area for 8-10 min before applying the hUCMSC-Exos in the entire face. And to compared with those used 1565 nm non-ablative fractional laser or microneedles combined with hUCMSC-Exos.

Trial Locations (1)

350001

RECRUITING

Affiliated Union Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER